Open Book Extracts Launches Research Study On Minor Cannabinoids For Relaxation And Calmness

Open Book Extracts launched a placebo-controlled trial of minor cannabinoid formulations to improve relaxation and calmness.

The most prevalent mental health disorder in the world is anxiety. Globally, an estimated 284 million people experienced anxiety disorders in 2017, with women being diagnosed at twice the rate of men. To address this market need, OBX developed and tested distinct formulas designed to help people unwind (relaxation) and/or clear their mind (calmness).

Based on scientific literature and real-world anecdotal feedback, six active ingredients were selected and formulated to promote two distinct mood states: relaxation and calmness. The cannabinoids selected were CBD, CBG, CBC, and CBDV, and the polyphenols selected were Quercetin and Curcumin. The primary criteria for selecting candidates was evidence of anxiolytic-like effects with minimal sedative-like effects. Secondary criteria included alterations in mood, sleep, and/or cognitive performance.

A randomized, double-blinded, placebo-controlled evaluation is being conducted to determine the efficacy of these products. Self-reported outcomes will be collected and reported on relaxation and stress. The study will be virtual and with no in-person visits. A secure online software service will allow for anonymous tracking of the real-time experiences of study products.

"Too many people who are struggling with mental health issues also struggle with gaining access to effective, non-pharmaceutical solutions," stated Andrea Baillo, OBX chief scientific officer. "The OBX Relaxation Study will test distinct formulations of cannabinoids and other bioactives, to better understand their ability to improve relaxation, stress, and overall well-being."

Benzinga's Cannabis Capital Conference Is Back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.

Photo by Tim Foster on Unsplash

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsMarketsAndrea BailloOpen Book Extractspremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on – Prices will increase very soon!